Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr James Larkin, a postdoctoral researcher from Nicola Sibson’s lab in the CRUK/MRC Oxford Institute for Radiation Biology, has won a silver medal in 2018 STEM for Britain, a Parliamentary poster competition that gives researchers the chance to present their work to policymakers and politicians and discuss their work with local MPs.

STEM for Britain, organised by the Parliamentary and Scientific Committee with support from the Royal Society of Biology, Royal Academy of Engineering, Royal Society of Chemistry and the Institute of Physics, is open to early career researchers engaged in scientific, engineering, technological or medical research.

James, alongside more than 40 bioscientists at the event, presented his research on brain tumour diagnostics, taking one of three medals home from the competition. His research is on developing a technique to diagnose brain tumours as early as possible by profiling the metabolites in urine samples.

Around one in five cancer patients develop secondary tumours, or metastases, which spread to the brain. These are hard to diagnose early using current techniques and late-stage diagnosis limits therapeutic options. James and the team have shown that this novel technique can be used to diagnose and track development of metastases in mice and are now trialling the same methods in patients with brain metastases.

On winning the award, James said, "I had a great time at the STEM for Britain event and met a number of people interested in my research and its applications. To be recognised with an award as well is a fantastic honour and I would like to thank the judges for their confidence in my work.

"In addition, I would like to thank my funders, Cancer Research UK and the Medical Research Council, for supporting this work, as well as my colleagues and collaborators, without whom none of this project would be possible."
Stephen Metcalfe MP, chair of the Parliamentary and Scientific Committee, said: "This annual competition is an important date in the parliamentary calendar because it gives MPs an opportunity to speak to a wide range of the country's best young researchers.

"These early career engineers, mathematicians and scientists are the architects of our future and STEM for Britain is politicians' best opportunity to meet them and understand their work."

Similar stories

Multi-cancer blood test shows real promise in NHS trial

An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.

The Howat Foundation to fund Chair in Clinical Oncology

Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation

New Oxford and Nottingham developed tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years

A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called ‘CanPredict’, aimed at identifying the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.

Oxford gets £122m funding for healthcare research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the city’s two National Institute for Health and Care Research (NIHR) Biomedical Research Centres (BRC).

The Department represented at the European Radiation Research Society annual conference

Researchers from the Department of Oncology attend the prestigious European Radiation Research Society (ERRS) in annual conference in Catania, Italy to present their research in Radiation Oncology.